Want to see MRNA full AI Analyst Report?
Moderna (MRNA) Stock Statistics & Valuation Metrics
Total Valuation
Moderna has a market cap or net worth of $88.52B. The enterprise value is $24.02B.
- Market Cap
- $88.52B
- Enterprise Value
- $24.02B
Share Statistics
Moderna has 399,235,900 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 399,235,900
- Owned by Insiders
- 7.78%
- Owned by Institutions
- 58.26%
Financial Efficiency
Moderna’s return on equity (ROE) is -0.33 and return on invested capital (ROIC) is -29.70%.
- Return on Equity (ROE)
- -0.33
- Return on Assets (ROA)
- -0.23
- Return on Invested Capital (ROIC)
- -29.70%
- Return on Capital Employed (ROCE)
- -0.30
- Revenue Per Employee
- 413.62K
- Profits Per Employee
- -600.43K
- Employee Count
- 4,700
- Asset Turnover
- 0.16
- Inventory Turnover
- 5.67
Valuation Ratios
The current PE Ratio of Moderna is -27.67. Moderna’s PEG ratio is 3.28.
- PE Ratio
- -27.67
- PS Ratio
- 39.57
- PB Ratio
- 12.93
- Price to FCF
- -72.09
- Price to Operating Cash Flow
- -83.13
- PEG Ratio
- 3.28
Income Statement
In the last 12 months, Moderna had revenue of 1.94B and earned -2.82B in profits. Earnings per share was -7.26.
- Revenue
- 1.94B
- Gross Profit
- 1.08B
- Operating Income
- -3.07B
- Pretax Income
- -2.77B
- Net Income
- -2.82B
- EBITDA
- -2.55B
- Earnings Per Share (EPS)
- -7.26
Cash Flow
In the last 12 months, operating cash flow was -1.05B and capital expenditures -171.00M, giving a free cash flow of -1.22B billion.
- Operating Cash Flow
- -1.05B
- Free Cash Flow
- -1.22B
- Free Cash Flow per Share
- -3.09
Dividends & Yields
Moderna pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -1.39%
- Earnings Yield
- -3.60%
Stock Price Statistics
- Beta
- 0.89
- 52-Week Price Change
- 713.07%
- 50-Day Moving Average
- 182.49
- 200-Day Moving Average
- 87.29
- Relative Strength Index (RSI)
- 56.91
- Average Volume (3m)
- 21.32M
Important Dates
Moderna upcoming earnings date is Nov 06, 2026, Before Open (Not Confirmed).
- Last Earnings Date
- Jul 31, 2026
- Next Earnings Date
- Nov 06, 2026
- Ex-Dividend Date
- ―
Financial Position
Moderna as a current ratio of 3.29, with Debt / Equity ratio of 22.15%
- Current Ratio
- 3.29
- Quick Ratio
- 3.22
- Debt to Market Cap
- 0.11
- Net Debt to EBITDA
- 0.27
- Interest Coverage Ratio
- -307.40
Taxes
In the past 12 months, Moderna has paid 54.00M in taxes.
- Income Tax
- 54.00M
- Effective Tax Rate
- -0.02
Enterprise Valuation
Moderna EV to EBITDA ratio is -31.01, with an EV/FCF ratio of -71.73.
- EV to Sales
- 39.37
- EV to EBITDA
- -31.01
- EV to Free Cash Flow
- -71.73
- EV to Operating Cash Flow
- -83.39
Balance Sheet
Moderna has $5.14B in cash and marketable securities with $1.29B in debt, giving a net cash position of $3.85B billion.
- Cash & Marketable Securities
- $5.14B
- Total Debt
- $1.29B
- Net Cash
- $3.85B
- Net Cash Per Share
- $9.65
- Tangible Book Value Per Share
- $16.67
Margins
Gross margin is -12.57%, with operating margin of -149.01%, and net profit margin of -141.43%.
- Gross Margin
- -12.57%
- Operating Margin
- -149.01%
- Pretax Margin
- -138.55%
- Net Profit Margin
- -141.43%
- EBITDA Margin
- -126.97%
- EBIT Margin
- -137.79%
Analyst Forecast
The average price target for Moderna is $127.69, which is 11.43% higher than the current price. The consensus rating is Neutral
- Price Target
- $127.69
- Price Target Upside
- 42.18% Downside
- Analyst Consensus
- Neutral
- Analyst Count
- 20
- Revenue Growth Forecast
- -27.62%
- EPS Growth Forecast
- -6.22%
Scores
- Smart Score
- 6
- AI Score
- 56
